The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of indications arise. Although these technological developments represent remarkable progress in knowing neurodegenerative diseases, they may have https://fionai208enx7.celticwiki.com/user